leupeptin and nafamostat
leupeptin has been researched along with nafamostat in 8 studies
Research
Studies (8)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 3 (37.50) | 2.80 |
Authors
Authors | Studies |
---|---|
Agarwal, M; Chugani, R; Han, Z; Harris, PK; Janetka, JW; Jones, DE; Kim, T; Shen, W; Wildman, SA | 1 |
Pilgram, O; Steinmetzer, T; Wenzel, BM; Wiedemeyer, SJA | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Ino, Y; Iwaki, M; Sato, T; Suzuki, K | 1 |
Andoh, T; Kuraishi, Y; Lee, JB; Nojima, H; Ui, H | 1 |
Jenkins, G; Knox, A; Pang, L; Porte, J; Tatler, AL | 1 |
Coffin, AB; Mamiya, A; Raible, DW; Rubel, EW; Williamson, KL | 1 |
Chinnasamy, K; Iruthayaraj, A; Kandasamy, S; Magudeeswaran, S; Poomani, K; Ramakrishnan, J | 1 |
Other Studies
8 other study(ies) available for leupeptin and nafamostat
Article | Year |
---|---|
Inhibitors of HGFA, Matriptase, and Hepsin Serine Proteases: A Nonkinase Strategy to Block Cell Signaling in Cancer.
Topics: | 2014 |
Fibrinolysis Inhibitors: Potential Drugs for the Treatment and Prevention of Bleeding.
Topics: Animals; Antifibrinolytic Agents; Catalytic Domain; Crystallography, X-Ray; Fibrinolysin; Fibrinolysis; Hemorrhage; Humans; Ligands; Molecular Structure; Plasminogen; Protein Binding; Protein Domains | 2020 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
[Comparative studies of nafamostat mesilate and various serine protease inhibitors in vitro].
Topics: alpha-Macroglobulins; Aprotinin; Benzamidines; Complement Inactivator Proteins; Gabexate; Glycoproteins; Guanidines; Hemolysis; In Vitro Techniques; Leupeptins; Protease Inhibitors; Protein Binding | 1986 |
Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice.
Topics: Animals; Antibodies; Antipruritics; Benzamidines; Dose-Response Relationship, Drug; Extravasation of Diagnostic and Therapeutic Materials; Guanidines; Histamine; Histamine H1 Antagonists; Injections, Intradermal; Leupeptins; Male; Mast Cells; Mice; Mice, Inbred ICR; Mice, Mutant Strains; Oligopeptides; p-Methoxy-N-methylphenethylamine; Pruritus; Receptor, PAR-2; Serine Endopeptidases; Serotonin; Skin; Terfenadine; Time Factors; Tryptases | 2006 |
Tryptase activates TGFbeta in human airway smooth muscle cells via direct proteolysis.
Topics: Benzamidines; Bronchi; Guanidines; Humans; Leupeptins; Myocytes, Smooth Muscle; Oligopeptides; Receptor, PAR-2; Transforming Growth Factor beta; Trypsin Inhibitors; Tryptases | 2008 |
Profiling drug-induced cell death pathways in the zebrafish lateral line.
Topics: Animals; Antioxidants; Benzamidines; Calpain; Caspase Inhibitors; Cell Death; Cells, Cultured; Cisplatin; Cross-Linking Reagents; Gentamicins; Guanidines; Hair Cells, Auditory, Inner; Lateral Line System; Leupeptins; Methionine; Neomycin; Oligopeptides; Protease Inhibitors; Protein Synthesis Inhibitors; Reactive Oxygen Species; Zebrafish | 2013 |
Strong Binding of Leupeptin with TMPRSS2 Protease May Be an Alternative to Camostat and Nafamostat for SARS-CoV-2 Repurposed Drug: Evaluation from Molecular Docking and Molecular Dynamics Simulations.
Topics: Antiviral Agents; Benzamidines; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Esters; Guanidines; Humans; Leupeptins; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Binding; SARS-CoV-2; Serine Endopeptidases | 2021 |